| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
1 company
Tom Y Lee last filed a Form 4 in August 2024, as Chief Executive Officer at PURE. Tom Y Lee's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 5,001,843 shares of PURE. Net of sales, the PURE filings show accumulation of 23,382,205 shares.
Tom Y Lee has 27 Form 4 filings on record from July 2015 to August 2024, all as Director, 10% Owner at Pure Bioscience (PURE), 2015–2024.
The 63 reported transactions were 22 open-market purchases, 21 option or other derivative awards, 6 stock awards and 5 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 9 purchases worth about $2.1M and 1 sale worth about $14K.
The largest open-market purchase was 2,336,187 shares of PURE at an average $0.45 on August 16, 2018, about $1.1M.
The only open-market sale was 14,885 shares of PURE at an average $0.95 on December 21, 2016, about $14K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | PURE Pure Bioscience, Inc. | Chief Executive Officer | Buy | 50,000 | $0.13 | $6,550.00 | +1.0% | |
| Mar 21, 2022 | PURE Pure Bioscience, Inc. | Chief Executive Officer | Buy | 219,477 | $0.20 | $42,822.61 | +4.6% | |
| Jun 16, 2021 | PURE Pure Bioscience, Inc. | Chief Executive Officer | Buy | 35,998 | $0.43 | $15,515.14 | +0.8% | |
| Dec 24, 2020 | PURE Pure Bioscience, Inc. | Chief Executive Officer | Buy | 78,721 | $0.66 | $52,248.01 | +1.7% | |
| Jun 22, 2020 | PURE Pure Bioscience, Inc. | Chief Executive Officer | Buy | 53,124 | $1.76 | $93,570.28 | +1.2% | |
| Jun 17, 2020 | PURE Pure Bioscience, Inc. | Chief Executive Officer | Buy | 202,033 | $1.74 | $351,870.69 | +4.6% | |
| Dec 19, 2019 | PURE Pure Bioscience, Inc. | Director | Buy | 754,884 | $0.29 | $218,161.48 | +3.4% | |
| Oct 2, 2019 | PURE Pure Bioscience, Inc. | Director | Buy | 1,000,000 | $0.29 | $290,000.00 | +4.7% | |
| Aug 16, 2018 | PURE Pure Bioscience, Inc. | Director | Buy | 2,336,187 | $0.45 | $1,051,284.15 | +12.5% | |
| Dec 29, 2017 | PURE Pure Bioscience, Inc. | Director | Buy | 18,666,666 | $0.00 | - | New |